new cancer drug
REGISTRATION
PATIENT
Before entering the patient portal make sure to obtain a patient ID and password by registering.
PHYSICIAN
If you are a physician and would like to enter the physician portal, please register above.
CONTACT US
Back to Saficor
 
new cancer research
 mechanismLab StudiesToxicity ProfileClinical StudyContact Us

A moment's thought would have shown him. But a moment is a long time; and thought is a painful process. A. E. Houseman
 
Introduction

Safinur is a bi-molecular system patented for its anti-tumor activity

This site contains scientific information on Safinur's effects on tumor cells in vitro, in animals and in humans. The active components in Safinur are non-toxic and have been patented for their anti-tumor activity. 


new cancer drug 

The anti-tumor properties of Safinur were discovered by SAFICOR scientist based in California. Using tissue culture techniques and biochemical methods, Saficor scientists are continuing work to determine the mechanisms of action and properties of Safinur. To get more information on Saficor's research efforts in the field of cancer or our seminar schedule for 2008 email us at scientist@safinur.com.

   
 
new cancer drug 

One mechanism of action identified recently is Safinur's ability to interfere with cytoskeleton polymerization. The cytoskeleton is composed of multiple elements as shown below. The cytoskeleton is a crucial non-redundant system that plays a major role in cellular physiology and is a natural target for anti-tumor compounds. 

 
new cancer drug

Historically, molecules that target the cytoskeleton were effective chemotherapies but were highly toxic. Saficor's discovery of an agent that targets the cytoskeleton and has minimal or no toxicity is a major advance in the field of cancer therapeutics.


Clinical Study: 

 

Educational corner: Cytoskeleton components and function in the cell

new cancer drug


If you have any questions regarding information contained in this website, please give us a call at 714-532-4632 or email us at info@safinur.com

 

Saficor, Technology, Business, Employment, Contact,
Cancer, Mechanism, Lab Studies, Toxicity,
Clinical Study, Registration, Patient Portal, Physician portal
Enrollment New Patients, Continuing Patients
 

Saficor, Orange, California USA; Copyright Saficor 2006 all rights reserved

Disclaimer

 The information contained here is not intended as a substitute for medical professional help or advice but is to be used only for informational purposes. A physician should always be consulted for any health problem or medical condition. Safinur has not yet undergone organized clinical trials for cancer. It is provided as a dietary supplement for clinical study. Before taking this or other dietary supplements consult your physician. Safinur has been shown to be uniquely non-toxic in many animal studies; however, systematic human studies on toxicity have not been conducted. Statements made on this website have not been evaluated by the FDA and are not meant to diagnose, treat, cure or prevent any disease.

Saficor, Orange, California USA; Copyright Saficor 2006 all rights reserved